KFF.orgState Health Facts - Your source for state health data
Kaiser Family Foundation Kaiser Health News Kaiser Family Foundation

     Choose a different category...

HIV/AIDS 
Cumulative AIDS Cases
New AIDS Cases
Annual AIDS Case Rate
Persons Living with AIDS
Cumulative Reported HIV Infections (Cases)
Annual Reported HIV Infections (Cases)
Deaths
HIV/AIDS Funding
Ryan White Program
AIDS Drug Assistance Program (ADAP)
HIV Testing
HIV in Prisons
Other HIV/AIDS-Related Policies
Print

AIDS Drug Assistance Programs (ADAP) Formularies, Number of Medications by Drug Class, as of December 31, 2008

|
|
|

Show:

Rank By:
|

United StatesNumber0 - 0
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)NA
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)NA
Protease Inhibitors (10 Drugs)NA
Fusion Inhibitors (1 Drug)NA
CCR5 Antagonists (1 Drug)NA
Integrase Inhibitors (1 Drug)NA
Multi-Class Combination Products (1 Drug)NA
"A1" OI Medications (31 DHHS Recommended Drugs)NA
Other MedicationsNA


AlabamaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)3
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)21
Other Medications3

AlaskaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)28
Other Medications26

ArizonaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)11
Other Medications121

ArkansasNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)17
Other Medications59

CaliforniaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)25
Other Medications122

ColoradoNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)18
Other Medications52

ConnecticutNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)16
Other Medications144

DelawareNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)24
Other Medications196

District of ColumbiaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)19
Other Medications38

FloridaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)14
Other Medications52

GeorgiaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)17
Other Medications13

HawaiiNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)27
Other Medications55

IdahoNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)3
Protease Inhibitors (10 Drugs)7
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)3
Other Medications0

IllinoisNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)31
Other Medications39

IndianaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)24
Other Medications77

IowaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)21
Other Medications18

KansasNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)8
Other Medications17

KentuckyNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)3
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)14
Other Medications21

LouisianaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)28
Other Medications3

MaineNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)31
Other Medications268

MarylandNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)22
Other Medications96

MassachusettsNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)31
Other MedicationsOpen formulary

MichiganNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)23
Other Medications131

MinnesotaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)13
Other Medications83

MississippiNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)3
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)28
Other Medications10

MissouriNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)21
Other Medications188

MontanaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)15
Other Medications71

NebraskaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)15
Other Medications80

NevadaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)12
Other Medications37

New HampshireNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)31
Other MedicationsOpen formulary

New JerseyNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)31
Other MedicationsOpen formulary

New MexicoNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)13
Other Medications30

New YorkNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)27
Other Medications410

North CarolinaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)19
Other Medications73

North DakotaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)8
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)19
Other Medications48

OhioNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)11
Other Medications59

OklahomaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)10
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)13
Other Medications7

OregonNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)21
Other Medications45

PennsylvaniaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)27
Other Medications33

Rhode IslandNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)3
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)16
Other Medications22

South CarolinaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)19
Other Medications15

South DakotaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)12
Other Medications17

TennesseeNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)3
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)14
Other Medications29

TexasNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)9
Other Medications7

UtahNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)14
Other Medications3

VermontNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)16
Other Medications39

VirginiaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)21
Other Medications45

WashingtonNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)23
Other Medications110

West VirginiaNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)15
Other Medications25

WisconsinNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)20
Other Medications17

WyomingNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)28
Other Medications51


GuamNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)12
Other MedicationsNA

Puerto RicoNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)9
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)19
Other Medications21

Virgin IslandsNumber0 - 410
 
Nucleoside Reverse Transcriptase Inhibitors (11 Drugs)11
Non-Nucleoside Reverse Transcriptase Inhibitors (4 Drugs)4
Protease Inhibitors (10 Drugs)10
Fusion Inhibitors (1 Drug)1
CCR5 Antagonists (1 Drug)1
Integrase Inhibitors (1 Drug)1
Multi-Class Combination Products (1 Drug)1
"A1" OI Medications (31 DHHS Recommended Drugs)31
Other Medications3



(show/hide notes)
Notes: 

54 ADAPs reported data. American Samoa, Federated States of Micronesia, Marshall Islands, and Northern Mariana Islands did not report data.

Fortovase (saquinavir soft-gel) is no longer marketed by the manufacturer. The National ADAP Monitoring Project Annual Report counts Fortovase and Invirase (saquinavir hard-gel) as one drug for the purposes of tabulating the number of protease inhibitors covered on an ADAP's formulary.

Atripla is a multi-class combination product that includes efavirenz (NNRTI), emtricitabine (NRTI), and tenofovir disoproxil fumarate (NRTI). In addition, the multi-class combination products listed above are not considered a class of drugs since their component parts are included in other drug classes, and are therefore not required to be included in ADAP formularies. Examples of "Other Medications" include those used to treat depression, hypertension, and diabetes.
Sources: 

National ADAP Monitoring Project Annual Report, National Alliance of State and Territorial AIDS Directors, Kaiser Family Foundation, April 2009, available at http://www.kff.org/hivaids/ADAP.cfm and at http://www.nastad.org.

Definitions: 

ADAP: AIDS Drug Assistance Program.
"A1" OI Medications: Medications highly recommended for the prevention and treatment of opportunistic infections.
DHHS: Department of Health and Human Services.




     Help
KFF.org Kaiserhealthnews.org Kaiseredu.org
Search Contact Us Email Subscriptions Privacy Statement